Adaptive Continual Reassessment Method: A Maximum Tolerated Dose Estimation Method in Phase I Clinical Trial
KOREAN JOURNAL OF APPLIED STATISTICS（2024）
Key words
phase I clinical trial,maximum tolerated dose,3+3 design,continual reassessment method,modified continual reassessment method
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined